Valeri Marina, Cieri Miriam, Elefante Grazia Maria, De Carlo Camilla, Rudini Noemi, Lughezzani Giovanni, Buffi Nicolò Maria, Terracciano Luigi Maria, Colombo Piergiuseppe
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Department of Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Clinical and Research Hospital, Rozzano, Italy.
Front Med (Lausanne). 2022 Feb 7;9:835599. doi: 10.3389/fmed.2022.835599. eCollection 2022.
Renal medullary carcinoma (RMC) is a rare entity with poor prognosis bearing inactivating genomic alterations in resulting in the loss of expression of INI1 and occurring in young patients with sickle cell trait or sickle cell disease. Recently, rare examples with histological characteristics of RMC have been described in older patients without hemoglobinopathies and provisionally termed "Renal cell carcinoma unclassified with medullary phenotype" (RCCU-MP). Fluorescence Hybridization (FISH) can detect alterations in consisting mostly in inactivating translocation of one allele and deletion of the second. To date, only seven further cases of RCCU-MP have been described in the literature. Here we report the second Italian case of RCCU-MP, a 62-year-old man presenting with persistent dull back pain and incidentally discovering a 13 cm mass in the right kidney. The nomenclature of this entity is still debated and might be updated as a variant of medullary carcinoma in the upcoming WHO classification. In the meantime, we encourage awareness of these extraordinarily rare neoplasms with poor outcomes.
肾髓质癌(RMC)是一种罕见的实体瘤,预后较差,存在导致INI1表达缺失的基因组失活改变,多见于患有镰状细胞性状或镰状细胞病的年轻患者。最近,在无血红蛋白病的老年患者中发现了具有RMC组织学特征的罕见病例,并暂称为“具有髓质表型的未分类肾细胞癌”(RCCU-MP)。荧光原位杂交(FISH)可检测INI1基因的改变,主要包括一个等位基因的失活易位和另一个等位基因的缺失。迄今为止,文献中仅另有7例RCCU-MP病例报道。在此,我们报告第二例意大利RCCU-MP病例,一名62岁男性,因持续性钝痛就诊,偶然发现右肾有一个13厘米的肿块。该实体瘤的命名仍存在争议,可能会在即将到来的世界卫生组织分类中作为髓质癌的一种变体进行更新。同时,我们鼓励大家提高对这些预后极差的罕见肿瘤的认识。